Pharmarise Holdings (TSE:2796) EV-to-EBITDA : 11.14 (As of May. 26, 2024)

Pharmarise Holdings EV-to-EBITDA Chart

Pharmarise Holdings Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
EV-to-EBITDA		Get a 7-Day Free Trial					6.82	6.11	5.12	4.76	4.41

Pharmarise Holdings Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial															9.11	4.41	9.05	6.79	11.20

Competitive Comparison of Pharmarise Holdings's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmarise Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's EV-to-EBITDA falls into.

Pharmarise Holdings EV-to-EBITDA Calculation

Pharmarise Holdings's EV-to-EBITDA for today is calculated as:

Pharmarise Holdings's current Enterprise Value is 円12,752 Mil.
Pharmarise Holdings's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmarise Holdings  (TSE:2796) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmarise Holdings's PE Ratio for today is calculated as:

Pharmarise Holdings's share price for today is 円654.00.
Pharmarise Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円24.848.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Pharmarise Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings (TSE:2796) Business Description